Penn Medicine scientists blend AI and ingenuity to transform mRNA gene editing and personalized therapies redefining modern medicine
Search Results: pharmaceutical companies (245)
A new international pricing analysis underscores that the United States remains the most expensive country in the world for brand-name prescription drugs.
On July 1, 1946, the world watched, literally, through newsreels and radio broadcasts, as the United States detonated “Able,” the first of 23 nuclear tests that would transform Bikini Atoll from paradise to laboratory
Michigan Rep. Shri Thanedar faces online backlash after calling to abolish ICE following a fatal Minneapolis shooting.
Biopharmaceutical company AbbVie has reached an agreement with the Trump administration to invest $100 billion in its U.S. operations
At a Leadership @ Inflection Points conference, two CFOs share candid insights on navigating capital constraints, uncertainty and high-stakes financial decisions.
Johnson & Johnson agrees to cut U.S. drug prices, gain Trump tariff exemptions, expand Medicaid access, and boost domestic manufacturing.
An investor’s postcard on how the UAE is rapidly emerging as a global hub for biotech, AI, and life sciences.
A powerful profile of Dr. David Fajgenbaum using AI drug repurposing to cure rare diseases and transform medicine.
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
After dismantling the Department of Education, President Donald Trump is turning his attention towards healthcare.
Trump’s meeting with NYC Mayor Zohran Mamdani highlights a high-stakes political pivot centered on America’s deepening affordability crisis.
Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.
Hippocratic AI raises $126 million in Series C funding, reaching a $3.5 billion valuation to scale safe, generative AI healthcare solutions.
Trump’s plan to impose steep import taxes on pharmaceuticals — some as high as 200% — is drawing sharp warnings from industry experts who fear it could push up drug prices in the United States and trigger shortages
President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies demanding they lower U.S. drug prices to match international levels, with a September 29 deadline
The U.S.–EU trade agreement sparks uncertainty in the pharmaceutical sector, risking $100 billion in EU investments and disrupting global drug supply chains and innovation.
AstraZeneca has announced plans to invest $50 billion in the U.S. by 2030 amid concerns over tariffs
Argon AI raises $5.5M seed funding to build an AI-native workspace unifying life sciences data, empowering teams to automate tasks and elevate strategic decision-making.
The same psychological and cultural forces that built U.S. steel empires and digital platforms are now constructing the biotech infrastructure that will define the next American century.
U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace
Kishore’s thesis examines venture capital’s critical role in funding the production of life sciences innovation and life-saving therapies
Solve Intelligence makes use of artificial intelligence (AI) to speed up the work of intellectual property and patent lawyers.
At the Indiaspora Forum for Good, Shah emphasized the need for vocational education, domestic manufacturing, and innovation to reduce dependence on imports and strengthen India’s economy.
Most Asian Americans oppose cutting federal agencies and mass layoffs while wanting the government to focus on everyday costs